| Mrs Felicia M Molano, LMHC, NCC | |
|
2370 130th Ave Ne Ste 104, Bellevue, WA 98005-1770 | |
| (425) 628-2820 | |
| Not Available |
| Full Name | Mrs Felicia M Molano |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 2370 130th Ave Ne Ste 104, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013166065 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | LH00011036 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Felicia M Molano, LMHC, NCC 2370 130th Ave Ne Ste 104, Bellevue, WA 98005-1770 Ph: (425) 628-2820 | Mrs Felicia M Molano, LMHC, NCC 2370 130th Ave Ne Ste 104, Bellevue, WA 98005-1770 Ph: (425) 628-2820 |
News Archive
Marshall Edwards, Inc., an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that it was notified on November 16, 2010 by the Listing Qualifications Staff of The NASDAQ Stock Market that, due to the Company's non-compliance with the minimum $10 million stockholders' equity requirement for continued listing on The NASDAQ Global Market, as set forth in Listing Rule 5450(b)(1), the Company's common stock is subject to delisting unless the Company requests a hearing before a NASDAQ Listing Qualifications Panel.
In a paper published today in the journal Scientific Reports, a pair of researchers at the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences report that inhibiting the ability of immune cells to use fatty acids as fuel measurably slows disease progression in a mouse model of multiple sclerosis.
Scientists at the Alzheimer's Association International Conference on Alzheimer's Disease 2010 today presented the first draft reports from three workgroups convened by the National Institute on Aging and the Alzheimer's Association to update the diagnostic criteria for Alzheimer's disease for the first time in 25 years.
Researchers from Sweden's Chalmers University of Technology and the University of Gothenburg present a new method which can double the energy of a proton beam produced by laser-based particle accelerators.
Sens. Charles Schumer (D-N.Y.) and Susan Collins (R-Maine) on Thursday introduced legislation (S 726) that would allow FDA to approve generic versions of biotechnology drugs after a five-year period of brand-name patent exclusivity, the New York Times reports.
› Verified 3 days ago
Susan Begin Burns, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 2370 130th Ave Ne Ste 106, Bellevue, WA 98005 Phone: 425-881-9000 Fax: 425-746-8016 | |
Kevin Sosa, LMHCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 12507 Ne Bel Red Rd Ste 103, Bellevue, WA 98005 Phone: 253-642-6127 | |
Ms. Jessica Kicha, MA Counselor Medicare: Not Enrolled in Medicare Practice Location: 1400 112th Ave Se, Suite 100, Bellevue, WA 98004 Phone: 425-243-4722 | |
Jonny Andrew Cragg, MA LMHCA Counselor Medicare: Not Enrolled in Medicare Practice Location: 1400 112th Ave Se Ste 202, Bellevue, WA 98004 Phone: 917-434-0855 | |
Amy Martin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 14216 Ne 21st St, Bellevue, WA 98007 Phone: 425-653-4900 | |
Ross Benson, SUDP Counselor Medicare: Not Enrolled in Medicare Practice Location: 12330 Ne 8th St Ste 100, Bellevue, WA 98005 Phone: 425-454-2238 Fax: 425-455-8482 | |
Hsin Yu Yang, Counselor Medicare: Not Enrolled in Medicare Practice Location: 999 164th Ave Ne, Bellevue, WA 98008 Phone: 425-747-4937 |